What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Roger E. McLendon mostly deals with Cancer research, Glioma, Pathology, Stem cell and Internal medicine.
His Cancer research study combines topics in areas such as Mutation, IDH1, Phenotype and Epidermal growth factor receptor.
His biological study spans a wide range of topics, including Tumor microenvironment, Cancer, O6-Benzylguanine, ATRX and Alkyltransferase.
Roger E. McLendon interconnects Viremia and Anaplastic astrocytoma, Astrocytoma, Oligodendroglioma in the investigation of issues within Pathology.
His studies deal with areas such as Cancer cell and Immunology as well as Stem cell.
His Internal medicine research focuses on Oncology and how it relates to Bevacizumab, Clinical endpoint and Molecular analysis.
His most cited work include:
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (5484 citations)
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (4594 citations)
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (4410 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Glioma, Cancer research, Internal medicine and Oncology.
Roger E. McLendon focuses mostly in the field of Pathology, narrowing it down to matters related to Monoclonal antibody and, in some cases, Antigen.
His work carried out in the field of Glioma brings together such families of science as Survival rate, Molecular biology, IDH1 and Alkyltransferase.
The various areas that Roger E. McLendon examines in his Cancer research study include Mutation, Cancer, Epidermal growth factor receptor and Stem cell.
His Mutation study results in a more complete grasp of Genetics.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
He most often published in these fields:
- Pathology (40.71%)
- Glioma (26.59%)
- Cancer research (25.18%)
What were the highlights of his more recent work (between 2014-2021)?
- Cancer research (25.18%)
- Pathology (40.71%)
- Glioma (26.59%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Pathology, Glioma, Internal medicine and Cancer.
His Cancer research research includes themes of CD155, Gene, DNA methylation and Immunotherapy.
His Pathology research is multidisciplinary, incorporating elements of Pilocytic astrocytoma, Central neurocytoma and Ganglioglioma.
His Glioma research is multidisciplinary, relying on both Tumor microenvironment, IDH1, Brain tumor, Radioresistance and Regulation of gene expression.
His Internal medicine research incorporates themes from Gastroenterology and Oncology.
His Cancer research incorporates elements of Congenital cytomegalovirus infection and Family medicine.
Between 2014 and 2021, his most popular works were:
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (1510 citations)
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth (398 citations)
- The whole-genome landscape of medulloblastoma subtypes (376 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Cancer research, Cancer, DNA methylation, Glioma and Gene.
His Cancer research study incorporates themes from Mutation, Pathology, Chromatin, microRNA and Signal transduction.
His work is dedicated to discovering how Mutation, Phenotype are connected with ATRX and other disciplines.
Roger E. McLendon has included themes like Congenital cytomegalovirus infection, Chemotherapy and Oncology in his Cancer study.
Roger E. McLendon works in the field of Glioma, focusing on Astrocytoma in particular.
His work on Carcinogenesis as part of general Gene study is frequently connected to Statistical analysis, Confusion and Characterization, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
